An article in the Medical Science monitor dated May 4, 2014 reported about a small study from the Riordan Clinic in Wichita, Kansas. Nina Mikirova and Ronald Hunninghake treated 35 men and women with chronic fatigue syndrome and other conditions who had documented positive Epstein Barr virus antibodies in their test results. The patients received intravenous vitamin C solutions at various dosages ranging from 7.5 to 50 grams. 32 of these patients experienced improvement after the treatment. When 5 or more vitamin C infusions were given, the subjects had a significantly greater decrease of EBV antibody titer reduction when compared to patients who did not receive vitamin C infusions. Clinically the patients who had a decrease in EBV antibodies also experienced a significant improvement in the symptoms of their chronic fatigue syndrome.
The same group had previously found that high doses of vitamin C could be used to reduce inflammatory markers like C-reactive protein in rheumatoid arthritis, heart disease, and lung disease and in peripheral neuropathy. Vitamin C is required to synthesize collagen, which is one of the most abundant proteins in our bodies. Collagen is also the major component of connective tissue. Vitamin C has antioxidant properties, which stops the inflammatory reactions in the body.
Epstein Barr virus is instrumental or plays a role in the causation of Burkitt’s lymphoma, chronic fatigue syndrome, Hodgkin’s disease, mononucleosis and some autoimmune diseases.
For more info on EBV and mononucleosis see this link.
Reference: Med Sci Mon. 2014 May 4.